HypoglycemiaHyperglycemiaTreatment OutcomeDiabetes Mellitus, Type 1Blood GlucoseDiabetes MellitusInsulinDiabetes Mellitus, Type 2Hypoglycemic AgentsDiabetes ComplicationsDiabetes Mellitus, ExperimentalGlucagonHemoglobin A, GlycosylatedGlucoseHyperinsulinismPostoperative ComplicationsBlood Glucose Self-MonitoringGlucose Clamp TechniqueEpinephrineInsulin Infusion SystemsPancreatic PolypeptideTime FactorsInsulin, Long-ActingC-PeptideRisk FactorsClinical AlarmsInsulin ComaRetrospective StudiesGlucose Tolerance TestIslets of LangerhansDiabetes, GestationalSulfonylurea CompoundsVentromedial Hypothalamic NucleusFollow-Up StudiesStreptozocinFastingNesidioblastosisCongenital HyperinsulinismInsulinomaHydrocortisoneProspective StudiesPregnancy in DiabeticsGluconeogenesisInsulin-Secreting CellsInfant, NewbornPancreas, ArtificialDiabetic NeuropathiesMetforminInsulin ResistanceGlipizideDiabetic KetoacidosisNorepinephrinePostprandial PeriodDiabetic NephropathiesHomeostasisPregnancyInsulin LisproReference ValuesMonitoring, AmbulatoryDiabetic RetinopathyInsulin AspartGlucagon-Like Peptide 1PancreasInsulin, IsophaneFatty Acids, NonesterifiedRats, Sprague-DawleyLiverIncidence3-Hydroxybutyric AcidInsulin AntibodiesAwarenessInfusions, SubcutaneousDiazoxideDipeptidyl-Peptidase IV InhibitorsPancreatectomyGlucokinaseCohort StudiesObesityBody WeightIntraoperative ComplicationsDiabetic AngiopathiesCritical IllnessAutonomic Nervous SystemHuman Growth HormoneInfusions, IntravenousRats, Inbred BBPregnancy ComplicationsVenomsInsulin, Regular, PorkPrediabetic StateGlucose IntoleranceRisk AssessmentSeverity of Illness IndexRecurrenceMonitoring, PhysiologicPrevalenceLactic AcidBrainDisease Models, AnimalGlucagon-Secreting Cells